Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00243321 · ClinicalTrials.gov registry record · NA
High Dose-Rate Brachytherapy and/or Intensity Modulated External Beam Radiation Therapy for Prostate Cancer
A NA study, sponsored by Virginia Commonwealth University.
- Completed
- Registry status
- NA
- Development phase
- 27
- Enrollment target
NCT00243321 is a NA study that has completed, run by Virginia Commonwealth University. The registered enrollment target is 27 participants.
The verdict
NCT00243321, a NA study, has completed, sponsored by Virginia Commonwealth University.
- COMPLETED
- Registry status
- NA
- Development phase
- 27 participants
- Enrollment target
Study Summary
The principal objective of this study is to demonstrate that patients can safely receive combined High Dose Rate brachytherapy and Intensity-Modulated Radiation Therapy without experiencing a treatment limiting toxicity.
Interventions
- PROCEDURE high dose-rate brachytherapy
- PROCEDURE intensity-modulated radiation therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2003-02 |
| Est. Completion | 2012-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00243321
The ClinicalTrials.gov registry entry for NCT00243321 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which high dose-rate brachytherapy is the first listed.
NCT00243321 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00243321 about?
NCT00243321 is a clinical study titled "High Dose-Rate Brachytherapy and/or Intensity Modulated External Beam Radiation Therapy for Prostate Cancer". The principal objective of this study is to demonstrate that patients can safely receive combined High Dose Rate brachytherapy and Intensity-Modulated Radiation Therapy without experiencing a treatment limiting toxicity.
What is the current status of trial NCT00243321?
This trial is currently completed. It is a NA study. The enrollment target is 27 participants. The study started on 2003-02. Estimated completion is 2012-01.
What interventions are being tested in trial NCT00243321?
The interventions under investigation include: high dose-rate brachytherapy (PROCEDURE), intensity-modulated radiation therapy (PROCEDURE).
Who is sponsoring clinical trial NCT00243321?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.